Syncona Limited (SYNC) - Net Assets
Based on the latest financial reports, Syncona Limited (SYNC) has net assets worth GBX1.02 Billion GBX (≈ $124.22K USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (GBX1.03 Billion ≈ $125.89K USD) and total liabilities (GBX13.77 Million ≈ $1.68K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Syncona Limited (SYNC) asset resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | GBX1.02 Billion |
| % of Total Assets | 98.67% |
| Annual Growth Rate | 13.53% |
| 5-Year Change | -19.01% |
| 10-Year Change | 122.99% |
| Growth Volatility | 34.8 |
Syncona Limited - Net Assets Trend (2013–2025)
This chart illustrates how Syncona Limited's net assets have evolved over time, based on quarterly financial data. Also explore SYNC asset base for the complete picture of this company's asset base.
Annual Net Assets for Syncona Limited (2013–2025)
The table below shows the annual net assets of Syncona Limited from 2013 to 2025. For live valuation and market cap data, see SYNC company net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | GBX1.05 Billion ≈ $128.13K |
-15.00% |
| 2024-03-31 | GBX1.24 Billion ≈ $150.74K |
-1.26% |
| 2023-03-31 | GBX1.25 Billion ≈ $152.66K |
-4.21% |
| 2022-03-31 | GBX1.31 Billion ≈ $159.37K |
+0.73% |
| 2021-03-31 | GBX1.30 Billion ≈ $158.21K |
+4.31% |
| 2020-03-31 | GBX1.25 Billion ≈ $151.67K |
-14.33% |
| 2019-03-31 | GBX1.46 Billion ≈ $177.05K |
+37.83% |
| 2018-03-31 | GBX1.06 Billion ≈ $128.46K |
+17.93% |
| 2017-03-31 | GBX895.24 Million ≈ $108.92K |
+89.57% |
| 2016-03-31 | GBX472.25 Million ≈ $57.46K |
-1.42% |
| 2015-03-31 | GBX479.06 Million ≈ $58.29K |
+10.17% |
| 2014-03-31 | GBX434.85 Million ≈ $52.91K |
+89.39% |
| 2013-03-31 | GBX229.61 Million ≈ $27.94K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Syncona Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 100.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | GBX768.00 Million | 72.93% |
| Other Components | GBX285.08 Million | 27.07% |
| Total Equity | GBX1.05 Billion | 100.00% |
Syncona Limited Competitors by Market Cap
The table below lists competitors of Syncona Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Avenir Telecom S.A
PA:AVT
|
$6.59 Million |
|
Gencell Ltd
TA:GNCL
|
$6.59 Million |
|
Craneware Plc
LSE:CRW
|
$6.59 Million |
|
Altheora SA
PA:ALORA
|
$6.59 Million |
|
Progressive Impact Corporation Bhd
KLSE:7201
|
$6.58 Million |
|
Trio Petroleum Corp.
NYSE MKT:TPET
|
$6.58 Million |
|
cbdMD Inc
NYSE MKT:YCBD
|
$6.58 Million |
|
Pembangunan Graha Lestari Tbk
JK:PGLI
|
$6.58 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Syncona Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 1,238,878,000 to 1,053,080,000, a change of -185,798,000 (-15.0%).
- Net loss of 143,160,000 reduced equity.
- Share repurchases of 43,063,000 reduced equity.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | GBX-143.16 Million | -13.59% |
| Share Repurchases | GBX43.06 Million | -4.09% |
| Other Changes | GBX425.00K | +0.04% |
| Total Change | GBX- | -15.00% |
Book Value vs Market Value Analysis
This analysis compares Syncona Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 53.82x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 80.13x to 53.82x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2013-03-31 | GBX1.11 | GBX89.00 | x |
| 2014-03-31 | GBX1.75 | GBX89.00 | x |
| 2015-03-31 | GBX1.25 | GBX89.00 | x |
| 2016-03-31 | GBX1.23 | GBX89.00 | x |
| 2017-03-31 | GBX1.94 | GBX89.00 | x |
| 2018-03-31 | GBX1.59 | GBX89.00 | x |
| 2019-03-31 | GBX2.17 | GBX89.00 | x |
| 2020-03-31 | GBX1.88 | GBX89.00 | x |
| 2021-03-31 | GBX1.94 | GBX89.00 | x |
| 2022-03-31 | GBX1.95 | GBX89.00 | x |
| 2023-03-31 | GBX1.88 | GBX89.00 | x |
| 2024-03-31 | GBX1.86 | GBX89.00 | x |
| 2025-03-31 | GBX1.65 | GBX89.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Syncona Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -13.59%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: -0.06x
- • Equity Multiplier: 1.01x
- Recent ROE (-13.59%) is below the historical average (4.90%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | 26.70% | 92.66% | 0.29x | 1.00x | GBX38.35 Million |
| 2014 | 2.19% | 70.76% | 0.03x | 1.01x | GBX-33.95 Million |
| 2015 | 10.37% | 89.83% | 0.11x | 1.01x | GBX1.77 Million |
| 2016 | -0.21% | -21.05% | 0.01x | 1.01x | GBX-48.22 Million |
| 2017 | 8.63% | 92.94% | 0.09x | 1.01x | GBX-12.23 Million |
| 2018 | 16.37% | 87.98% | 0.18x | 1.01x | GBX67.25 Million |
| 2019 | 28.26% | 93.66% | 0.30x | 1.02x | GBX265.75 Million |
| 2020 | -15.69% | 0.00% | -0.13x | 1.02x | GBX-320.21 Million |
| 2021 | 4.09% | 67.68% | 0.06x | 1.03x | GBX-76.87 Million |
| 2022 | 0.67% | 47.28% | 0.01x | 1.02x | GBX-122.15 Million |
| 2023 | -4.46% | 0.00% | -0.03x | 1.01x | GBX-181.48 Million |
| 2024 | 0.31% | 12.32% | 0.02x | 1.01x | GBX-120.10 Million |
| 2025 | -13.59% | 0.00% | -0.06x | 1.01x | GBX-248.47 Million |
Industry Comparison
This section compares Syncona Limited's net assets metrics with peer companies in the Asset Management industry.
Industry Context
- Industry: Asset Management
- Average net assets among peers: $745,852,800
- Average return on equity (ROE) among peers: 2.99%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Syncona Limited (SYNC) | GBX1.02 Billion | 26.70% | 0.01x | $6.59 Million |
| 3I Infrastructure PLC (3IN) | $1.20 Billion | 4.98% | 0.15x | $42.14 Million |
| Albion Enterprise VCT PLC (AAEV) | $61.87 Million | 11.55% | 0.03x | $3.29 Million |
| abrdn Asian Income Fund Limited (AAIF) | $431.87 Million | 14.17% | 0.08x | $5.17 Million |
| Abrdn Asia Focus PLC (AAS) | $98.67 Million | 9.82% | 0.09x | $7.49 Million |
| Albion Technology & General VCT PLC (AATG) | $64.83 Million | 5.63% | 0.01x | $3.22 Million |
| Abrdn PLC (ABDN) | $4.56 Billion | 10.22% | 39.48x | $45.21 Million |
| Aberdeen Diversified Income and Growth Trust PLC (ADIG) | $426.87 Million | 6.29% | 0.20x | $450.86K |
| Aquila Energy Efficiency Trust PLC (AEET) | $69.67 Million | -2.91% | 0.02x | $261.59K |
| Aquila European Renewables Income PLC (AERI) | $372.54 Million | -8.03% | 0.00x | $79.35 Million |
| Artemis UK Future Leaders plc (AFL) | $174.91 Million | -21.80% | 0.02x | $415.29 |
About Syncona Limited
Syncona Limited is a fund specializes in investments in hedge, equity and long-term alternative investment funds across multiple asset classes. It manages private equity, debt, fixed income and alternative investments. The fund prefers to invest in healthcare and life sciences sector with focus on Cell therapy, gene therapy, biologics and small molecules. The fund invests in the public equity and… Read more